NCT02386774View on ClinicalTrials.gov

Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 21, 2016

Primary Completion Date

September 28, 2020

Study Completion Date

September 28, 2020

Conditions
Corneal DiseaseBlepharitisLacrimal Apparatus Diseases
Interventions
DEVICE

Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml

used anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml

DEVICE

Multifluorescence IVCM vivascope 1500 ML (Caliber/Mavig)

"used for Multifluorescence IVCM~* anesthesic eyedrop : oxybuprocaïne (1,6 mg/0,4 ml)~* Fluorescein 0,5%, Rose Bengal , Infracyanine"

PROCEDURE

microangiography

realization of the microangiography with intravenous injection of fluoresceine and indocyanine green.

Trial Locations (2)

42055

Chu de Saint Etienne, Saint-Etienne

Chu de Saint Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02386774 - Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa | Biotech Hunter | Biotech Hunter